ADL
CRSP icon

Asset Dedication LLC’s CRISPR Therapeutics CRSP Stock Holding History

Asset Dedication LLC’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-115
Closed -$6.03K – 1127
2025
Q4 		$6.03K Hold
115
– – ﹤0.01% 861
2025
Q3 		$7.45K Hold
115
– – ﹤0.01% 848
2025
Q2 		$5.59K Hold
115
– – ﹤0.01% 908
2025
Q1 		$3.91K Sell
115
-12
-9% -$509 ﹤0.01% 891
2024
Q4 		$5K Sell
127
-33
-21% -$1.56K ﹤0.01% 856
2024
Q3 		$7.52K Sell
160
-350
-69% -$17.8K ﹤0.01% 843
2024
Q2 		$27.5K Buy
510
+104
+26% +$6.02K ﹤0.01% 599
2024
Q1 		$28K Hold
406
– – ﹤0.01% 526
2023
Q4 		$25K Buy
406
+350
+625% +$19.3K ﹤0.01% 524
2023
Q3 		$2K Hold
56
– – ﹤0.01% 885
2023
Q2 		$3K Buy
56
+23
+70% +$1.3K ﹤0.01% 826
2023
Q1 		$1K Hold
33
– – ﹤0.01% 886
2022
Q4 		$1K Hold
33
– – ﹤0.01% 917
2022
Q3 		$2K Hold
33
– – ﹤0.01% 815
2022
Q2 		$2K Hold
33
– – ﹤0.01% 449
2022
Q1 		$2K Hold
33
– – ﹤0.01% 855
2021
Q4 		$3K Sell
33
-135
-80% -$11.8K ﹤0.01% 801
2021
Q3 		$19K Buy
168
+60
+56% +$7.54K ﹤0.01% 569
2021
Q2 		$17K Buy
108
+75
+227% +$9.12K ﹤0.01% 544
2021
Q1 		$4K Buy
+33
New +$4.98K ﹤0.01% 568

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Asset Dedication LLC's CRSP Position: Q1 2026 in Review

Asset Dedication LLC sold out of CRISPR Therapeutics (CRSP) in Q1 2026, closing a stake of 115 shares — an estimated $6.03K sold.

Asset Dedication LLC first reported a position in CRSP in Q1 2021 and held it in 20 quarters. The position peaked at $28K in Q1 2024. 491 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • Asset Dedication LLC reported no remaining CRISPR Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Asset Dedication LLC sold 115 CRISPR Therapeutics shares in Q1 2026, an estimated $6.03K.
  • Asset Dedication LLC first reported a position in CRISPR Therapeutics in Q1 2021 and held it in 20 quarters.
  • Asset Dedication LLC's CRISPR Therapeutics position peaked at $28K in Q1 2024.
  • 491 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.